yoohoocthulhu

7 ms·

1. 1.▲
   by yoohoocthulhu 10y ago

   The drug is cheap...because it's unpatentable (as a molecule anyway) and is old enough that any patents would be expired anyway. The marketing of autoinjectors has some legitimate public health value, but it's also a clear busines
2. 2.▲
   by yoohoocthulhu 10y ago

   I'd say that Theranos is so much of an outlier that it's failure won't really have a huge effect. They weren't patenting nor licensing any exciting technology. They had no groundbreaking presentations of their technolog
3. 3.▲
   by yoohoocthulhu 10y ago

   The diagnostics space is kind of screwed at the moment anyway by court rulings that have severely limited the patentability of diagnostics tests